Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2010
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210512 Thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
08/19/2010US20100210511 Combination VEGFR2 Therapy with Temozolomide
08/19/2010US20100210510 Oral lactoferrin in the treatment of sepsis
08/19/2010US20100210509 Long acting hyaluronic acid - peptide conjugate
08/19/2010US20100210508 Method for the Massive Culture of Cells Producing Recombinant Human Erythropoietin
08/19/2010US20100210507 Glycopegylated erythropoietin
08/19/2010US20100210506 Intranasal administration of rapid acting insulin
08/19/2010US20100210505 Polymer conjugates of glp-1
08/19/2010US20100210504 Enhanced transport using membrane disruptive agents
08/19/2010US20100209958 Method of treating arthritis and promoting growth of articular chondrocytes
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209541 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
08/19/2010US20100209532 Targeted oxygen delivery via intravenous or intra-arterial infusion of oxygenated polymerized hemoglobin solutions
08/19/2010US20100209526 Product comprising a combination of milk serum apoproteins and free fatty acids
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209518 Micro-particles, blood-substitute and method for forming same
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209505 Controlled release pharmaceutical formulations of nitazoxanide
08/19/2010US20100209502 Treatments Which Alleviate Functional Glycosylated Leptin Transport Factor for Controlling Weight and Obesity
08/19/2010US20100209499 Solid Oral Dosage Form Containing an Enhancer
08/19/2010US20100209497 Formulations for treating human and animal diseases
08/19/2010US20100209494 Liposomes and Uses Thereof
08/19/2010US20100209493 HLA-A2 Tumor Associated Antigen Peptides and Compositions
08/19/2010US20100209485 Stabilizing alkylglycoside compositions and methods thereof
08/19/2010US20100209474 Malleable implants containing demineralized bone matrix
08/19/2010US20100209468 Implantable devices for producing insulin
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209458 Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
08/19/2010US20100209447 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
08/19/2010US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
08/19/2010US20100209444 MAGE3 Polypeptides
08/19/2010US20100209443 Vaccine for the Prevention of Breast Cancer Relapse
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209441 Drug for suppressing pathogen occurring in vivo
08/19/2010US20100209440 Targeted Delivery of siRNA
08/19/2010US20100209436 Method for treating diseases related to mitochondrial dysfunction
08/19/2010US20100209433 Methods for the diagnosis and for the treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
08/19/2010US20100209431 Metal triangulo compound and methods of using the same
08/19/2010US20100209429 Peptides and methods for the treatment of gliomas and other cancers
08/19/2010US20100209419 Method and formulation for treating adverse biological conditions
08/19/2010US20100209415 Chemotherapeutic methods and compositions
08/19/2010US20100209414 Methods and Compositions Related to Cyclic Peptide Synthesis
08/19/2010US20100209413 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
08/19/2010US20100209412 Osteogenesis promoter
08/19/2010US20100209411 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
08/19/2010US20100209405 Sericin extracted silkworm fibroin fibers
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209393 Use of Polynucleotides Encoding Small Acid-Soluble Spore Protein for Inhibiting Bacterial Cell Growth and/or Treating Bacterial Infections
08/19/2010US20100209392 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
08/19/2010US20100209391 Novel inhibitors of hepatitis c virus replication
08/19/2010US20100209390 Cyclosporin analogues
08/19/2010US20100209389 Multi-Compartmented Container
08/19/2010US20100209388 Nutraceutical composition and method of use for treatment / prevention of cancer
08/19/2010US20100209387 Enhanced medical implant
08/19/2010US20100209386 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
08/19/2010US20100209385 Treatment of obesity
08/19/2010US20100209384 Sustained release formulations comprising very low molecular weight polymers
08/19/2010US20100209383 Use of g-csf for treating ischemia
08/19/2010US20100209361 Highly cationic copolymers based on quaternized nitrogen-containing monomers
08/19/2010US20100209357 Localized Therapy of Lower Airways Inflammatory Disorders with Proinflammatory Cytokine Inhibitors
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/19/2010US20100209350 Biomarkers for Adipose Tissue Activity
08/19/2010US20100209346 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
08/19/2010US20100209341 Treatment of chronic inflammatory conditions
08/19/2010US20100209340 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
08/19/2010CA2752433A1 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
08/19/2010CA2752237A1 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010CA2752182A1 Apolipoprotein a-i mimics
08/19/2010CA2752160A1 Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-.beta. superfamily members
08/19/2010CA2752157A1 Peripheral administration of proteins including tgf-.beta. superfamily members for systemic treatment of disorders and disease
08/19/2010CA2726230A1 The stabilisation of proteins
08/18/2010EP2219378A1 Method and system for providing a customized media list
08/18/2010EP2219031A1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
08/18/2010EP2218784A1 Vector(s) containing an inducible gene encoding a CDK4/CD6 inhibitor useful for treating neurodegenerative disorders
08/18/2010EP2218783A1 Novel method for the manufacturing of neurotoxins
08/18/2010EP2218782A2 Anti-OX40L Antibodies
08/18/2010EP2218779A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
08/18/2010EP2218736A1 Implant coated with multi-domain amphipathic helical peptides and methods of their use
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218734A2 Glucagon-like peptide-2 analogs
08/18/2010EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218716A1 Method for amplifying hematopoietic stem cells using heterocyclic compound
08/18/2010EP2218462A1 Pharmaceutical preparation for the treatment of depressive pathologies, comprising a protein with a high tryptophan/LNAAs (Large Neutral Amino Acids) ratio
08/18/2010EP2218459A1 Sustained release composition containing sdf-1
08/18/2010EP2218458A1 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
08/18/2010EP2218457A1 CD44v6 peptides as inhibitors of bacterial infections
08/18/2010EP2218456A1 Lectin compound for prophylaxis and/or treatment of undesired drug side effects
08/18/2010EP2218446A1 Method for producing microcapsule using solid fat
08/18/2010EP2217701A2 Glucagon antagonists
08/18/2010EP2217697A1 Use of lingo-4 antagonists in the treatment of conditions involving demyelination
08/18/2010EP2217626A1 Epitope for neutralizing antibodies
08/18/2010EP2217621A1 Insulin derivative
08/18/2010EP2217620A2 Variants of c-type natriuretic peptide
1 ... 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 ... 3163